Trastuzumab
monoclonal antibody · anticancer
Nothing to addWhat this medicine is for
Pharmacologically, Trastuzumab relates to the category “monoclonal antibody (anticancer)”. This medicine belongs to the “Other fields” field. Its indication is precise and set by the prescription.
In the case of Trastuzumab, this means: Treats a cancer. Its conditions of use depend on the situation, within the framework set by the doctor.
Under which brands it is found
Trastuzumab is found in around 8 presentations listed in France. It is available under various brand names and as generics.
- Herceptin
- Herzuma
- Kanjinti
- Ogivri
- Ontruzant
- Phesgo
- Trazimera
- Zercepac
Original brand-name products and generics deliver the same active substance; the choice between them is made with your doctor or pharmacist.
Do you need a supplement? No.
For Trastuzumab, we offer no supplement. No nutritional supplementation is seriously justified as an addition to this treatment, and we would rather write that than invent a need. Our range is limited to five classes of everyday medicines for which a targeted intake makes sense; outside of those, we do not sell for the sake of selling, and that is what gives weight to our five products.
Talk about it in the community
Members are already discussing the topic: sensations, doubts, everyday tips. People speak frankly here, without lecturing or prescribing.
Related molecules
To explore in the « Other areas » family and its neighbours.